Funding Opportunity: Joslin Diabetes Center 2018 Pilot & Feasibility Grants

August 28, 2017

Applications for 2018 Joslin Pilot & Feasibility grants now open to all Harvard/Affiliates.

The goal of the Pilot and Feasibility Study Program is to encourage research on diabetes and its complications by two target groups: young researchers in these fields who have not yet received significant NIH or other funding, and seasoned investigators either entering the diabetes field for the first time or exploring a completely new direction.

The program has been highly successful since its inception. Projects funded in past years have covered a wide range of topics in the fields of type 1 and type 2 diabetes and their complications, including the control of insulin gene expression, mechanisms of insulin action and resistance, stem cell biology, beta cell apoptosis and potential renewal, mechanisms of leptin action and resistance, and autoantigen therapy of type 1 diabetes. The approaches have also been very diverse, covering wide varieties of biochemical, molecular biologic, genetic, immunological and clinical strategies. This breadth reflects the interests of Joslin’s diabetes research program as a whole; see more about Joslin’s Research Programs.

Letters of intent are due Friday, Sept 15, 2017; invited complete applications are due Friday, Oct 13, 2017. $50,000/year x 2 year grants will be awarded Jan 1, 2018 for two outstanding proposals to study diabetes and its complications from basic, translational and/or clinical perspectives. Please see the website for complete details on eligibility and how to apply.

For further questions about the grant and the application process, email: PandF@Joslin.Harvard.Edu.